Ad
related to: norah o'donnell bio
Search results
Nosh.bio sidesteps many challenges constraining alt-protein with a versatile mycoprotein and...
Food Navigator USA· 2 hours agoNosh.bio’s CEO recently told FoodNavigator-USA at Future Food-Tech in San Francisco that the...
Beverly Hills Private Wealth LLC Sells 170 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)
ETF DAILY NEWS· 6 hours agoBeverly Hills Private Wealth LLC lowered its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 15.7% during the 4th quarter, according ...
Third Harmonic Bio Inc CEO Natalie Holles Sells 13,558 Shares
GuruFocus.com via Yahoo Finance· 16 hours agoNatalie Holles, CEO of Third Harmonic Bio Inc (NASDAQ:THRD), has sold 13,558 shares of the company...
Mustang Bio stock tumbles 27% amid news of mass layoffs (NASDAQ:MBIO)
Seeking Alpha· 19 hours agoMustang Bio (MBIO) stock tumbled 27% Monday in the wake of news that the company plans to cut around...
AmplifyBio and RNAV8 Bio Announce Strategic Partnership to Support mRNA Therapeutic Developers from...
Digital Journal· 4 hours agoThe combined offering will be ideal for mRNA drug developers who require discovery and optimization with in silico...
Class Action Filed Against bluebird bio, Inc. (BLUE) Seeking Recovery for Investors - Contact The...
FOX 23 News Albany· 5 hours agoThe Gross Law Firm issues the following notice to shareholders of bluebird bio, Inc. (NASDAQ: BLUE). Shareholders who purchased shares of BLUE during the class period listed ...
Gaumont Announces Development Of Six-Part Bio-Series On French First Lady Brigitte Macron
Deadline via Yahoo News· 1 hour agoFrench film and TV company Gaumont has announced it is developing a six-part drama devoted to French...
Earnings call: OncoCyte outlines growth strategy and partnership with Bio-Rad By Investing.com
Investing.com· 1 day agoDuring the earnings call, CEO Josh Riggs provided insights into the company's strategic...
BLUEBIRD BIO, INC. (NASDAQ: BLUE) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the...
Morningstar· 23 hours agoDo you, or did you, own shares of bluebird bio, Inc. (NASDAQ: BLUE)? Did you purchase your shares between April 24, 2023 and December 8, 2023, inclusive? Did you lose money ...
Imugene partners with Kincell Bio; selling cell therapy manufacturing facility for $6 million
Proactive Investors· 14 hours ago:IMU, OTC:IUGNF) managing director and CEO Leslie Chong sits down with Proactive’s Jonathan Jackson...